Arnulf Ferlitsch
Impact in
- Hepatology top 0.2%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 74
- Liver Disease and Transplantation 61
- Hepatitis C virus research 11
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Epidemiology 37
- Liver Disease Diagnosis and Treatment 36
- Co-authors
- Markus Peck‐Radosavljevic (77 shared papers)Thomas Reiberger (81 shared papers)Michael Trauner (83 shared papers)Mattias Mandorfer (56 shared papers)Philipp Schwabl (43 shared papers)B.A. Payer (17 shared papers)Wolfgang Sieghart (22 shared papers)Monika Ferlitsch (32 shared papers)
In The Last Decade
Arnulf Ferlitsch
147 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 116
- Hepatology 3.5k
- Epidemiology 2.4k
- Surgery 1.2k
- Gastroenterology 121
- Pharmacology 191
Countries citing papers authored by Arnulf Ferlitsch
This map shows the geographic impact of Arnulf Ferlitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnulf Ferlitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnulf Ferlitsch more than expected).
Fields of papers citing papers by Arnulf Ferlitsch
This network shows the impact of papers produced by Arnulf Ferlitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnulf Ferlitsch. The network helps show where Arnulf Ferlitsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnulf Ferlitsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 291 | |
| 2 | 2012 | 275 | |
| 3 | 2016 | 253 | |
| 4 | 2012 | 252 | |
| 5 | 2020 | 186 | |
| 6 | 2012 | 168 | |
| 7 | 2018 | 142 | |
| 8 | 2012 | 139 | |
| 9 | 2014 | 135 | |
| 10 | 2020 | 132 | |
| 11 | 2002 | 127 | |
| 12 | 2017 | 111 | |
| 13 | 2020 | 107 | |
| 14 | 2012 | 105 | |
| 15 | 2009 | 101 | |
| 16 | 2011 | 101 | |
| 17 | 2007 | 97 | |
| 18 | 2006 | 85 | |
| 19 | 2011 | 85 | |
| 20 | 2018 | 81 |
About Arnulf Ferlitsch
Arnulf Ferlitsch is a scholar working on Hepatology, Epidemiology, Oncology, Surgery and Infectious Diseases, having authored 158 papers that have together received 5.9k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (61 papers), Liver Disease Diagnosis and Treatment (36 papers), Colorectal Cancer Screening and Detection (12 papers), Hepatitis C virus research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Organ Transplantation Techniques and Outcomes (7 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (3.5k citations), Epidemiology (2.4k citations), Surgery (1.2k citations), Gastroenterology (121 citations) and Pharmacology (191 citations). Arnulf Ferlitsch has collaborated with scholars based in Austria, Germany and Spain. Frequent co-authors include Markus Peck‐Radosavljevic, Thomas Reiberger, Michael Trauner, Mattias Mandorfer, Philipp Schwabl, B.A. Payer, Wolfgang Sieghart, Monika Ferlitsch, Matthias Pinter and Theresa Bucsics. Their work appears in journals such as Journal of Hepatology, Liver International, Alimentary Pharmacology & Therapeutics, Endoscopy and Gastrointestinal Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.